Literature DB >> 16377016

Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.

Martin Werle1, Martin Hoffer.   

Abstract

The aim of the present study was to evaluate the influence of glutathione (GSH), the thiomer chitosan-4-thiobutylamidine (chitosan-TBA) and a combination of both compounds on P-glycoprotein (P-gp) activity. Permeation studies were performed with freshly excised guinea pig ileum mounted in Ussing chambers using the fluorescent dye rhodamine-123 (Rho-123) as P-gp substrate. Apparent permeability coefficients (Papp) as well as efflux ratios (secretory Papp/absorptive Papp) were calculated and compared with values gained from experiments with the well-established P-gp inhibitors terfenadine and verapamil. In the presence of terfenadine, verapamil as well as GSH, the absorptive transport of Rho-123 across intestinal tissue increased, while the secretory decreased with efflux ratios around 1.0. Chitosan-TBA and especially chitosan-TBA/GSH not only enhanced absorption of Rho-123, but also reduced the basolateral to apical secretion of Rho-123 resulting in efflux ratios of 1.1, 0.8 and 0.5. The study indicates that chitosan-TBA/GSH is a potentially valuable tool for inhibiting the ATPase activity of P-gp in the intestine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377016     DOI: 10.1016/j.jconrel.2005.11.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

Review 1.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

Review 2.  Advanced drug delivery systems of curcumin for cancer chemoprevention.

Authors:  Shyam S Bansal; Mehak Goel; Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-05

3.  The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate.

Authors:  Duangkamon Sakloetsakun; Glen Perera; Juliane Hombach; Gioconda Millotti; Andreas Bernkop-Schnürch
Journal:  AAPS PharmSciTech       Date:  2010-07-29       Impact factor: 3.246

4.  Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Ranko Skrbic; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Arch Drug Inf       Date:  2008-07

5.  Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.

Authors:  Amit K Sharma; Li Zhang; Shu Li; David L Kelly; Valery Yu Alakhov; Elena V Batrakova; Alexander V Kabanov
Journal:  J Control Release       Date:  2008-07-30       Impact factor: 9.776

6.  Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.

Authors:  Siva Ram Kiran Vaka; S M Sammeta; Lainy B Day; S Narasimha Murthy
Journal:  J Pharm Sci       Date:  2009-10       Impact factor: 3.534

Review 7.  Polymers influencing transportability profile of drug.

Authors:  Vinod L Gaikwad; Manish S Bhatia
Journal:  Saudi Pharm J       Date:  2013-10       Impact factor: 4.330

8.  N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.

Authors:  Cihui Tian; Sajid Asghar; Yifan Wu; Daddy Kambere Amerigos; Zhipeng Chen; Mei Zhang; Lining Yin; Lin Huang; Qineng Ping; Yanyu Xiao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties.

Authors:  K Gradauer; S Dünnhaupt; C Vonach; H Szöllösi; I Pali-Schöll; H Mangge; E Jensen-Jarolim; A Bernkop-Schnürch; R Prassl
Journal:  J Control Release       Date:  2012-12-08       Impact factor: 9.776

10.  Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Paul J Fawcett; Svetlana Golocorbin-Kon; Ivan Mikov; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jan-Mar       Impact factor: 2.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.